Assuming parkinson's is required, the following results were found.

  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS

    Living near major roads or highways is linked to higher incidence of dementia, Parkinson's disease, Alzheimer's disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health. Researchers from the...

    https://mschristian.org/index.php/articles/2-uncategorised/9836-living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms
  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS - YubaNet

    January 24, 2020 – Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health....

    https://mschristian.org/index.php/articles/2-uncategorised/9849-living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms-yubanet
  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS - YubaNet

    January 24, 2020 – Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health....

    https://mschristian.org/index.php/component/easyblog/living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms-yubanet?Itemid=341
  • Cell Therapy Shows Promise in Parkinson’s

    Dopaminergic progenitor cells derived from a Parkinson's disease patient's own skin cells and injected into his putamen showed evidence of survival and were associated with improved motor scores and quality of life measures. The cells were implanted...

    https://mschristian.org/index.php/component/easyblog/cell-therapy-shows-promise-in-parkinson-s?Itemid=101
  • Cell Therapy Shows Promise in Parkinson’s

    Dopaminergic progenitor cells derived from a Parkinson's disease patient's own skin cells and injected into his putamen showed evidence of survival and were associated with improved motor scores and quality of life measures. The cells were implanted...

    https://mschristian.org/index.php/articles/2-uncategorised/10810-cell-therapy-shows-promise-in-parkinson-s
  • World Brain Day: Hot Topics in Parkinson Disease

    This year, the World Federation of Neurology partnered with the International Parkinson and Movement Disorder Society to spotlight advancements in Parkinson disease. By: Alicia Bigica - July 22, 2020 Jill Giordano Farmer, DO, MPH On this World Brain...

    https://mschristian.org/index.php/articles/2-uncategorised/10976-world-brain-day-hot-topics-in-parkinson-disease
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    LOUISVILLE, Ky.--(BUSINESS WIRE)--The National Stem Cell Foundation (NSCF) announced today that research teams from Aspen Neuroscience and the New York Stem Cell Foundation (NYSCF) Research Institute will send a first-in-kind study of neurodegenerative...

    https://mschristian.org/index.php/component/easyblog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire?Itemid=341
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    LOUISVILLE, Ky.--(BUSINESS WIRE)--The National Stem Cell Foundation (NSCF) announced today that research teams from Aspen Neuroscience and the New York Stem Cell Foundation (NYSCF) Research Institute will send a first-in-kind study of neurodegenerative...

    https://mschristian.org/index.php/articles/2-uncategorised/9425-first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Beyond Motor Symptom Wearing-off in Parkinson’s Disease – What Are We Missing?

    Authors: Olivier Rascol , Hubert Fernandez , Per Odin , Joaquim J Ferreira European Neurological Review. 2020;15(Suppl. 1):2–7 Abstract In the treatment of Parkinson’s disease (PD), wearing-off refers to the recurrence of motor (and non-motor) symptoms...

    https://mschristian.org/index.php/component/easyblog/beyond-motor-symptom-wearing-off-in-parkinson-s-disease-what-are-we-missing?Itemid=341
  • Beyond Motor Symptom Wearing-off in Parkinson’s Disease – What Are We Missing?

    Authors: Olivier Rascol , Hubert Fernandez , Per Odin , Joaquim J Ferreira European Neurological Review. 2020;15(Suppl. 1):2–7 Abstract In the treatment of Parkinson’s disease (PD), wearing-off refers to the recurrence of motor (and non-motor) symptoms...

    https://mschristian.org/index.php/articles/2-uncategorised/10598-beyond-motor-symptom-wearing-off-in-parkinson-s-disease-what-are-we-missing
  • Apathy Predicts Dementia; More COVID Neuro Findings; Parkinson's Immunotherapy - MedPage Today

    dementia. (Alzheimer's & Dementia) The first study of a specific active immunotherapy against alpha-synuclein in Parkinson's disease, PD01A, showed it was safe and well-tolerated over 3 to 5 years. (Lancet Neurology) PTC857, an investigational...

    https://mschristian.org/index.php/articles/2-uncategorised/10950-apathy-predicts-dementia-more-covid-neuro-findings-parkinson-s-immunotherapy-medpage-today
  • New insights into how immune system and inflammation play a role in PD

    by Kate Anderton, B.Sc. (Editor)Nov 14 2019 Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of...

    https://mschristian.org/index.php/component/easyblog/new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd?Itemid=341
  • Why is my leg shaking?

    weight loss. A number of medications, such as beta-blockers and antithyroid medications, may help with the symptoms. Parkinson's disease is a condition of the nervous system that affects the brain and nerves. It causes shaking and other uncontrolled...

    https://mschristian.org/index.php/articles/2-uncategorised/9237-why-is-my-leg-shaking
  • New insights into how immune system and inflammation play a role in PD

    by Kate Anderton, B.Sc. (Editor)Nov 14 2019 Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of...

    https://mschristian.org/index.php/articles/2-uncategorised/9293-new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • Alzheimer’s Vaccine; Parkinson's PET Tracer; Fitness and Cognition

    (Alzheimer's Research & Therapy; PhillyVoice) Targeting the messenger RNA that encodes alpha synuclein may slow down Parkinson's disease progression. (PNAS) The FDA approved Fluorodopa F18, a PET tracer to help see damaged or lost nerve cells in people...

    https://mschristian.org/index.php/articles/2-uncategorised/9718-alzheimer-s-vaccine-parkinson-s-pet-tracer-fitness-and-cognition
  • Examining dopamine receptors in their natural environment

    research and for designing drugs for treating conditions in which the D2 receptor plays a fundamental part, including Parkinson's disease, psychosis, and addiction. Study leader Daniel Rosenbaum, Ph.D., an associate professor of biophysics and...

    https://mschristian.org/index.php/component/easyblog/examining-dopamine-receptors-in-their-natural-environment?Itemid=101
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    Nearly all major neurodegenerative diseases -- from Alzheimer's to Parkinson's -- are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such,...

    https://mschristian.org/index.php/component/easyblog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins?Itemid=341
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    Nearly all major neurodegenerative diseases -- from Alzheimer's to Parkinson's -- are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such,...

    https://mschristian.org/index.php/articles/2-uncategorised/4250-rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • Apathy Predicts Dementia; More COVID Neuro Findings; Parkinson's Immunotherapy - MedPage Today

    dementia. (Alzheimer's & Dementia) The first study of a specific active immunotherapy against alpha-synuclein in Parkinson's disease, PD01A, showed it was safe and well-tolerated over 3 to 5 years. (Lancet Neurology) PTC857, an investigational...

    https://mschristian.org/index.php/component/easyblog/apathy-predicts-dementia-more-covid-neuro-findings-parkinson-s-immunotherapy-medpage-today?Itemid=101
  • Alzheimer’s Vaccine; Parkinson's PET Tracer; Fitness and Cognition

    (Alzheimer's Research & Therapy; PhillyVoice) Targeting the messenger RNA that encodes alpha synuclein may slow down Parkinson's disease progression. (PNAS) The FDA approved Fluorodopa F18, a PET tracer to help see damaged or lost nerve cells in people...

    https://mschristian.org/index.php/component/easyblog/alzheimer-s-vaccine-parkinson-s-pet-tracer-fitness-and-cognition?Itemid=341

Results 1 - 20 of 86